Abstract | AIMS: MATERIALS & METHODS: RESULTS: Significant effects on the regulation of the VEGF receptors were observed in response to HDACi. These were associated with decreased secretion of VEGF, decreased cellular proliferation and increased apoptosis which could not be rescued by addition of exogenous recombinant VEGF. Direct remodeling of the VEGFR1 and VEGFR2 promoters was observed. In contrast, HDACi treatments resulted in significant downregulation of the Neuropilin receptors. CONCLUSION: Epigenetic targeting of the Neuropilin receptors may offer an effective treatment for lung cancer patients in the clinical setting.
|
Authors | Martin P Barr, Kenneth J O'Byrne, Nael Al-Sarraf, Steven G Gray |
Journal | Epigenomics
(Epigenomics)
Vol. 7
Issue 6
Pg. 897-910
( 2015)
ISSN: 1750-192X [Electronic] England |
PMID | 26479311
(Publication Type: Journal Article)
|
Chemical References |
- Histone Deacetylase Inhibitors
- Histones
- Hydroxamic Acids
- Vascular Endothelial Growth Factor A
- trichostatin A
- Vorinostat
- Receptors, Vascular Endothelial Growth Factor
|
Topics |
- Acetylation
- Apoptosis
(drug effects)
- Carcinoma, Non-Small-Cell Lung
(drug therapy, genetics, metabolism)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(genetics)
- Chromatin Assembly and Disassembly
(genetics)
- Epigenesis, Genetic
(drug effects)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Histone Deacetylase Inhibitors
(pharmacology)
- Histones
(metabolism)
- Humans
- Hydroxamic Acids
(pharmacology)
- Lung Neoplasms
(drug therapy, genetics, metabolism)
- Molecular Targeted Therapy
- Receptors, Vascular Endothelial Growth Factor
(genetics, metabolism)
- Vascular Endothelial Growth Factor A
(genetics, metabolism)
- Vorinostat
|